Navigation Links
Defibrillator for Public Access Emergencies from MADA Medical Now Offered by

Elberton, GA (PRWEB) September 22, 2013, an online e-commerce company that sells rehabilitation and medical supplies, has joined into a distribution agreement with MADA Medical, Incorporated, to offer the Samaritan® PAD Defibrillator to a wider consumer marketplace. As an international company headquartered in Carlstadt, New Jersey, MADA has been manufacturing and distributing hundreds of superior quality healthcare products since 1969. As a leading manufacturer and supplier of innovative respiratory equipment, infection control products and emergency lifesaving equipment, MADA's products are well utilized by the medical, pediatric, dental and veterinary fields.

With the ability to be taken and used virtually anywhere, the Samaritan® PAD Defibrillator made by HeartSine® that MADA distributes is specifically designed as a public access defibrillator (PAD). Portable, convenient and weighing in at only 2.4 pounds, the Samaritan is compact in size, but long on ability and durability. Carrying the industry's highest rating of IP56 against water and dust, this special defibrillator can be used in even the most inclement weather or environmental conditions. Resisting shocks and vibration, this unit highlights SCOPE™ Biphasic technology which has been reported to provide significantly improved performance in removing ventricular fibrillation (VF) by the third shock, and optimizing energy output for each individual patient.

The Samaritan is always ready once it is turned on, and easy-to-follow visual and verbal guides walk users through the defibrillation process that uses only two buttons for operation: the 'on' button and the 'shock' button. The Pad-Pak™ cartridge combines both the electrode pads and the battery, which typically has a shelf-life of 3.5 years from the date of manufacture, and can offer significant savings over other defibrillators that use separate battery and electrode pad units. An optional wall unit can be purchased separately to hold the Samaritan in a specific location, and features an alarm for added security.

Safety is further enhanced with the Samaritan's capability to analyze the patient's heart rhythm, and the unit will not deliver a shock unless it determines that the patient needs it, preventing accidents. “We are happy to introduce HeartSine's® lifesaving Samaritan® PAD Defibrillator via distribution from MADA Medical,” said Hulet Smith, OTR/L, MBA and CEO of Rehabmart. “With Sudden Cardiac Arrest (SCA) as a leading cause of death for people all over the world, response time is absolutely critical for survival. The Samaritan offers sophisticated defibrillation inside a compact and easy-to-use system that allows anyone to provide lifesaving medical assistance wherever and whenever this type of emergency occurs. We are very proud to offer this, and all of the premium quality healthcare products from MADA Medical to our customers at”


As an Occupational Therapist, the founder of Rehabmart, Hulet Smith, has the breadth of knowledge and experience necessary to match the needs of his customers with the very latest innovative products in the field of medical supplies and rehabilitation equipment. As a parent of special needs children, he has a personal interest in finding the best products to improve the lives of those who are disabled and medically challenged. is committed to provide superior customer service, competitive pricing and exceptional product offerings.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Pacemakers, Defibrillators Sources of Deadly Infections: Study
2. Implantable Defibrillators Linked to Decline in Cardiac Arrests
3. First FDA approved subcutaneous implantable defibrillator available for patients
4. People in crowdsourcing challenge find defibrillators in Philadelphia
5. Programming Change in Defibrillator Implants May Lower Death Risk: Study
6. Study shows how to reduce inappropriate shocks from implanted defibrillators
7. Women Dont Fare as Well as Men With Implanted Defibrillators: Study
8. Real-world patient survival with defibrillators matches trial expectations
9. Implanted Defibrillator Patients Prefer Device Off if Very Ill: Survey
10. Weight loss linked to higher risk with implanted defibrillators
11. Defibrillator Patients Who Lose Weight May Fare Worse
Post Your Comments:
(Date:6/27/2016)... Aliso Viejo, California (PRWEB) , ... June 27, 2016 , ... ... that are fully customizable inside of Final Cut Pro X," said Christina Austin - ... with another unique style. Final Cut Pro X users can now reveal ...
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: